School of Medicine


Showing 6,811-6,820 of 12,907 Results

  • Darren P. Lum

    Darren P. Lum

    Clinical Assistant Professor, Radiology

    Current Research and Scholarly InterestsPhase Contrast Flow MRI, Valvular Heart Disease, Cardiovascular MRI

  • Angela K. Lumba-Brown

    Angela K. Lumba-Brown

    Clinical Associate Professor, Emergency Medicine
    Clinical Associate Professor, Pediatrics

    Current Research and Scholarly InterestsCurrent research includes evidence-based guidelines for the management and treatment of traumatic brain injury, research establishing an evidence and targeting treatments for the subtypes of concussion, research identifying the best outcomes in pre-hospital care of patients with traumatic brain injury, research on brain performance via sensorimotor and sensory-cognitive synchronization, and research on dynamic visual synchronization as a biomarker for attentional impairments.

  • Gabriela Luna-Victoria

    Gabriela Luna-Victoria

    Casual - Non-Exempt, Obstetrics Anesthesiology

    Current Role at StanfordAdministrative Associate in the Department of Pediatrics, Division of Neonatal and Developmental Medicine at Stanford School of Medicine

    Administrative support to: Jochen Profit, Gary Darmstadt, Suzan Carmichael, Anca Pasca

  • Dennis Lund

    Dennis Lund

    Elizabeth Wood Dunlevie Professor, Emeritus

    BioDr. Lund was born in Duluth, MN and attended Harvard College and Harvard Medical School. He received his general surgical training at the MGH in Boston, and his pediatric surgical training at Boston Children's Hospital. His initial career was spent as a trauma, transplant and general pediatric surgeon at Boston Children's. In 1999, he became Surgeon-in-Chief of the University of Wisconsin Children's Hospital in in Madison, and in 2001 became Chair of General Surgery at the University of Wisconsin-Madison. In 2011, he became Executive Vice President of the Phoenix Children's Medical Group and Surgeon-in-Chief at Phoenix Children's Hospital. Dr. Lund joined the Stanford faculty in Pediatric Surgery and as Associate Dean of the Faculty in Pediatrics and Obstetrics (Clinical Affairs) as well as Chief Medical Officer at Lucile Packard Children's Hospital in March, 2015. In March of 2018 and through January of 2019, Dr. Lund served as interim President and CEO of Lucile Packard Children's Hospital.

  • Emma Lundberg

    Emma Lundberg

    Associate Professor of Bioengineering and of Pathology

    BioDr. Emma Lundberg is an Associate Professor of Bioengineering and Pathology at Stanford University and serves at the Director of the Cell Atlas of the Human Protein Atlas initiative in Sweden, where she is also Professor at KTH Royal Institute of Technology. At the intersection of bioimaging, proteomics, and artificial intelligence, her research aims to define the spatiotemporal organization of the human proteome at both cellular and subcellular level. Dr. Lundberg aims to develop integrated models of human cells to elucidate how variations in protein localization patterns influence cellular function, ultimately enabling the simulation of cell behavior and a systems-level understanding of how biological information is spatially encoded. The Lundberg Lab is responsible for creating the Subcellular Atlas of the Human Protein Atlas database (https://www.proteinatlas.org/). Dr. Lundberg is dedicated to building virtual cell models to simulate cell behavior, and is passionate about engaging the public in her work through citizen science games and computational challenges.

    Dr. Lundberg holds a Master’s degree in Bioengineering and a PhD in Biotechnology from KTH Royal Institute of Technology in Sweden. She has served as Secretary General of the Human Proteome Organization, and is actively involved in advisory roles for numerous open-access databases and cell mapping efforts such as the CZI AI Virtual Cell, Human Cell Atlas consortium, UniProt db, Reactome db, Human Proteome Project and various pharma and biotech companies. As a token of her leadership skills and advocate for open science, she was twice recognized as top 10 under 40 for future leaders in biopharma and omics.